alovudine has been researched along with Pulmonary Arterial Remodeling in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashek, A; Boellaard, R; Bogaard, HJ; Botros, L; Cupitt, J; Dabral, S; de Man, FS; Dubois, O; Frings, V; Harms, HJ; Huisman, MC; Jansen, S; Lammertsma, AA; Pullamsetti, SS; Spruijt, OA; Vonk Noordegraaf, A; Wharton, J; Wilkins, MR; Zhao, L | 1 |
1 other study(ies) available for alovudine and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
Topics: Adult; Aged; Animals; Case-Control Studies; Cell Proliferation; Cells, Cultured; Dideoxynucleosides; Disease Models, Animal; Equilibrative Nucleoside Transporter 1; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Humans; Ki-67 Antigen; Lung; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Predictive Value of Tests; Pulmonary Artery; Radiopharmaceuticals; Rats, Sprague-Dawley; Thymidine Kinase; Thymidine Phosphorylase; Vascular Remodeling | 2018 |